We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Refine your search

Content type


Firm name


708 results found


Arent Fox LLP | USA | 29 Oct 2018

HHS Proposes Disclosure of Drug Prices in TV Advertising, But Fight Over Authority On the Horizon

The Department of Health and Human Services (HHS) has issued a proposed rule (PR) which would require any television advertisement for a drug or


McGuireWoods LLP | USA | 16 Jul 2018

Washington Healthcare Update - Jul 16, 2018

In a two-day markup, the House Ways and Means Committee cleared a number of measures related to health savings accounts and a measure that would


Arent Fox LLP | USA | 6 Jun 2018

Connecticut and Maine Become the Latest States to Adopt New Drug Pricing Transparency Laws

Connecticut and Maine recently joined the increasing number of states to enact drug price transparency laws. Maine’s drug price transparency law (the


Jenner & Block LLP | USA | 26 Feb 2018

Anticipating This Year's HIPAA Enforcement Trends

We are a year into a new presidential administration, and yet it seems we are asking the same question that we were at this juncture last year: What


McGuireWoods LLP | USA | 19 Feb 2018

Washington Healthcare Update - Feb 19, 2018

While the President’s budget is not likely to be acted upon by Congress, it does signal what the administration’s priorities areas well as what


Skadden Arps Slate Meagher & Flom LLP | USA | 23 Jan 2018

As Congress Struggles With ACA Repeal, Trump Administration Moves Forward With Regulatory Reform

The Trump administration and Republican-led Congress spent substantial time and political capital in 2017 on efforts to repeal and replace the


Quarles & Brady LLP | USA | 20 Nov 2017

California Passes Two Drug Pricing Transparency Laws

Last month, California Governor Jerry Brown signed two new bills aimed at curtailing rising prescription drug costs, joining other states like


Reed Smith LLP | USA | 15 Nov 2017

FDA Finalizes Policy for Sharing Patient-Specific Data from Medical Devices

FDA recently released guidance ("Manufacturers Sharing Patient-Specific Information from Medical Devices with Patients Upon Request") finalizing its


McGuireWoods LLP | USA | 23 Oct 2017

Washington Healthcare Update - Oct 23, 2017

House Republicans and Democrats have failed to agree on how to pay for a five-year funding extension of the Children’s Health Insurance Program (CHIP)


Reed Smith LLP | USA | 2 Oct 2017

Fraud on the FDA? If Not Preempted, It Is Trumpery

With Bexis having originally conceived the preemption argument that became Buckman Co. v. Plaintiffs Legal Committee, 531 U.S. 341 (2001), we are

Previous page 1 2 3 ...